Brokerages Set DaVita Inc. (NYSE:DVA) Price Target at $155.80

DaVita Inc. (NYSE:DVA) has been assigned a consensus rating of “Hold” from the seven ratings firms that are covering the company, Marketbeat.com reports. One research analyst has rated the stock with a sell recommendation, four have given a hold recommendation, one has assigned a buy recommendation and one has given a strong buy recommendation to the company. The average 1-year target price among brokerages that have issued ratings on the stock in the last year is $155.80.

Several research analysts have weighed in on the company. Weiss Ratings reiterated a “hold (c)” rating on shares of DaVita in a report on Monday, December 29th. TD Cowen restated a “hold” rating on shares of DaVita in a report on Tuesday, February 3rd. UBS Group raised their price target on DaVita from $186.00 to $190.00 and gave the stock a “buy” rating in a research report on Wednesday, February 4th. Wall Street Zen upgraded DaVita from a “hold” rating to a “buy” rating in a research report on Saturday, February 21st. Finally, Zacks Research raised DaVita from a “hold” rating to a “strong-buy” rating in a research note on Wednesday, February 4th.

DaVita Stock Performance

Shares of NYSE:DVA opened at $150.94 on Monday. The company has a 50 day moving average price of $127.93 and a two-hundred day moving average price of $126.51. The company has a market capitalization of $10.08 billion, a PE ratio of 15.23, a PEG ratio of 0.53 and a beta of 0.94. DaVita has a 52 week low of $101.00 and a 52 week high of $159.42.

DaVita (NYSE:DVA) last announced its quarterly earnings results on Monday, February 2nd. The company reported $3.40 earnings per share for the quarter, topping analysts’ consensus estimates of $3.24 by $0.16. DaVita had a net margin of 5.47% and a negative return on equity of 413.18%. The company had revenue of $3.62 billion for the quarter, compared to analysts’ expectations of $3.51 billion. During the same period last year, the firm posted $2.24 earnings per share. The business’s quarterly revenue was up 9.9% compared to the same quarter last year. DaVita has set its FY 2026 guidance at 13.600-15.00 EPS. On average, sell-side analysts forecast that DaVita will post 10.76 earnings per share for the current year.

Institutional Investors Weigh In On DaVita

Several large investors have recently made changes to their positions in DVA. Hantz Financial Services Inc. lifted its position in DaVita by 48.1% during the 2nd quarter. Hantz Financial Services Inc. now owns 231 shares of the company’s stock worth $33,000 after buying an additional 75 shares in the last quarter. Elevation Wealth Partners LLC grew its holdings in shares of DaVita by 147.3% in the 4th quarter. Elevation Wealth Partners LLC now owns 277 shares of the company’s stock valued at $31,000 after acquiring an additional 165 shares in the last quarter. Caitlin John LLC acquired a new stake in shares of DaVita in the fourth quarter valued at about $34,000. Canada Pension Plan Investment Board bought a new stake in DaVita during the second quarter worth about $43,000. Finally, Sankala Group LLC acquired a new position in DaVita during the fourth quarter valued at approximately $39,000. Institutional investors own 90.12% of the company’s stock.

DaVita Company Profile

DaVita Inc (NYSE: DVA) is a leading provider of kidney care services, specializing in the management and operation of outpatient dialysis centers for patients with chronic kidney failure and end-stage renal disease. Headquartered in Denver, Colorado, the company offers a comprehensive suite of treatment modalities, including in-center hemodialysis, peritoneal dialysis, and home dialysis therapies. In addition to its core dialysis services, DaVita provides patient education, nutritional counseling, vascular access management and related laboratory services to support kidney health and overall patient well-being.

Since its formation in the mid-1990s through a clinical management services spin-off, DaVita has expanded both organically and through strategic partnerships and acquisitions.